Cargando…

The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo

Single-component adjuvant is prone to eliciting a specific type of Th1 or Th2 response. So, the development of combinatorial adjuvants inducing a robust mixed Th1/Th2 response is a promising vaccination strategy against cancer. Here, we describe a novel combination of aluminum salts (alum), CpG olig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Yaomei, Li, Meng, Yu, Chaoheng, Zhang, Rui, Zhang, Xueyan, Huang, Rong, Lu, Lian, Yuan, Fengjiao, Fan, Yingzi, Zhou, Bailing, Men, Ke, Xu, Heng, Yang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542240/ https://www.ncbi.nlm.nih.gov/pubmed/28515346 http://dx.doi.org/10.18632/oncotarget.17504

Ejemplares similares

Effective inhibition of melanoma tumorigenesis and growth via a new complex vaccine based on NY-ESO-1-alum-polysaccharide-HH2
por: Li, Meng, et al.
Publicado: (2014)

CpG-ODN Shapes Alum Adjuvant Activity Signaling via MyD88 and IL-10
por: Mirotti, Luciana, et al.
Publicado: (2017)

NY-ESO-1 Protein Vaccine Combining Alum, CpG ODN, and HH2 Complex Adjuvant Induces Protective and Therapeutic Anti-Tumor Responses in Murine Multiple Myeloma
por: Wang, Hao, et al.
Publicado: (2020)

Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanorings
por: Gungor, Bilgi, et al.
Publicado: (2014)

Characteristic of K3 (CpG-ODN) as a Transcutaneous Vaccine Formulation Adjuvant
por: Ito, Sayami, et al.
Publicado: (2020)

Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model
por: Golali, Ensieh, et al.
Publicado: (2012)

The effect of CpG-ODN on antigen presenting cells of the foal
por: Flaminio, M Julia BF, et al.
Publicado: (2007)

CpG ODN and ISCOMATRIX Adjuvant: A Synergistic Adjuvant Combination Inducing Strong T-Cell IFN-γ Responses
por: McCluskie, Michael J., et al.
Publicado: (2013)

Effect of CpG ODN on monocytic myeloid derived suppressor cells
por: Shirota, Hidekazu, et al.
Publicado: (2012)

TRAIL is involved in CpG ODN-mediated anti-apoptotic signals
por: LIM, EUN-JUNG, et al.
Publicado: (2011)

Immunogenicity evaluation of the HIV-1 Tat containing polyepitope DNA vaccine adjuvanted with CpG-ODNs in mice
por: Ollah Jazaeri, Ehsan, et al.
Publicado: (2021)

Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants
por: Liu, Haitao, et al.
Publicado: (2021)

Alum/CpG Adjuvanted Inactivated COVID-19 Vaccine with Protective Efficacy against SARS-CoV-2 and Variants
por: Zhang, Yuntao, et al.
Publicado: (2022)

Toll-like receptor 9 interaction with CpG ODN – An in silico analysis approach
por: Zhou, Wei, et al.
Publicado: (2013)

Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial
por: Ursu, Renata, et al.
Publicado: (2015)

CpG immunostimulatory oligodeoxynucleotide 1826 as a novel nasal ODN adjuvant enhanced the protective efficacy of the periodontitis gene vaccine in a periodontitis model in SD rats
por: Bai, Guohui, et al.
Publicado: (2021)

Radiosensitization by CpG ODN7909 in an epidermoid laryngeal carcinoma Hep-2 cell line
por: Wang, Shu, et al.
Publicado: (2017)

A plasmid containing CpG ODN as vaccine adjuvant against grass carp reovirus in grass carp Ctenopharyngodon idella
por: Su, Hang, et al.
Publicado: (2017)

Evaluation of CpG-ODN-Adjuvanted Toxoplasma gondii Virus-Like Particle Vaccine upon One, Two, and Three Immunizations
por: Kang, Hae-Ji, et al.
Publicado: (2020)

Limited Effect of CpG ODN in Preventing Type 1 Diabetes in NOD Mice
por: Lee, Byong Jun, et al.
Publicado: (2005)

Identification of Differentially Expressed lncRNAs in a CpG ODN-Activated Macrophage
por: Zheng, Ying, et al.
Publicado: (2020)

CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach
por: Zhang, Xiaofei, et al.
Publicado: (2023)

Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
por: Zhang, Rui, et al.
Publicado: (2019)

CpG-Containing Oligodeoxynucleotides and Freund Adjuvant in Combination with Alum Augment the Production of Monoclonal Antibodies Against Recombinant HBsAg
por: Khayyati Kohnehshahri, Mahsa, et al.
Publicado: (2022)

Induction and Amelioration of Methotrexate-Induced Gastrointestinal Toxicity are Related to Immune Response and Gut Microbiota
por: Zhou, Bailing, et al.
Publicado: (2018)

CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity
por: Jie, Jing, et al.
Publicado: (2018)

The Role of Liposomal CpG ODN on the Course of L. major Infection in BALB/C Mice
por: Hejazi, H, et al.
Publicado: (2010)

Increased Sensitivity to Chemotherapy Induced by CpG-ODN Treatment Is Mediated by microRNA Modulation
por: De Cecco, Loris, et al.
Publicado: (2013)

CpG-ODN Class C Mediated Immunostimulation in Rabbit Model of Trypanosoma evansi Infection
por: Kumar, Parveen, et al.
Publicado: (2015)

Pleiotropic action of CpG-ODN on endothelium and macrophages attenuates angiogenesis through distinct pathways
por: Wu, Jiahui, et al.
Publicado: (2016)

Treatment with phosphodiester CpG-ODN ameliorates atopic dermatitis by enhancing TGF-β signaling
por: Ham, Won-Kook, et al.
Publicado: (2021)

The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8(+) T-cell responses in vitro
por: Papagno, Laura, et al.
Publicado: (2020)

LNP-CpG ODN-adjuvanted varicella-zoster virus glycoprotein E induced comparable levels of immunity with Shingrix™ in VZV-primed mice
por: Luan, Ning, et al.
Publicado: (2022)

TLR9-mediated ARF6 activation is involved in advancing CpG ODN cellular uptake
por: Wu, Jing-Yiing, et al.
Publicado: (2012)

High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors
por: Sommariva, Michele, et al.
Publicado: (2013)

Preparation and characterization of PLGA nanospheres loaded with inactivated influenza virus, CpG-ODN and Quillaja saponin
por: Mohajer, Maryam, et al.
Publicado: (2014)

In Ovo Administration of CpG ODN Induces Expression of Immune Response Genes in Neonatal Chicken Spleen
por: Sajewicz-Krukowska, Joanna, et al.
Publicado: (2017)

CpG-ODN Attenuates Pathological Cardiac Hypertrophy and Heart Failure by Activation of PI3Kα-Akt Signaling
por: Yang, Liang, et al.
Publicado: (2013)

Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria
por: Wu, Xiaozhe, et al.
Publicado: (2017)

CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV
por: Zhao, Huajun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t91r00228ggbgdthsp6auti02k